Works matching AU Xing, Nianzeng

Results: 88
    1

    Erdafitinib versus Chemotherapy in Fibroblast Growth Factor Receptor-Altered Advanced or Metastatic Urothelial Cancer After Progression on Anti-programmed Death-(Ligand) 1 Therapy: An Exploratory Analysis of the Asian Subpopulation in the THOR Phase 3 Study

    Published in:
    Clinical Genitourinary Cancer, 2025, v. 23, n. 4, p. N.PAG, doi. 10.1016/j.clgc.2025.102376
    By:
    • Matsubara, Nobuaki;
    • Loriot, Yohann;
    • Burgess, Earle F.;
    • Park, Se Hoon;
    • Huddart, Robert A.;
    • Ku, Ja Hyeon;
    • Tran, Ben;
    • Huang, Jian;
    • Huang, Yi-Hsiu;
    • Nishimura, Kazuo;
    • Shimizu, Nobuaki;
    • Xing, Nianzeng;
    • Xue, Wei;
    • Hemaya, Rosemary;
    • Zhuo, Jianmin;
    • Deprince, Kris;
    • Triantos, Spyros;
    • Siefker-Radtke, Arlene O.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    High and selective cytotoxicity of ex vivo expanded allogeneic human natural killer cells from peripheral blood against bladder cancer: implications for natural killer cell instillation after transurethral resection of bladder tumor.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2024, v. 43, n. 1, p. 1, doi. 10.1186/s13046-024-02955-7
    By:
    • Wang, Fangming;
    • Zhang, Gang;
    • Xu, Tianli;
    • Ma, Jianlin;
    • Wang, Jing;
    • Liu, Shuai;
    • Tang, Yuzhe;
    • Jin, Song;
    • Li, Jianxing;
    • Xing, Nianzeng
    Publication type:
    Article
    43
    44
    45
    46
    47
    48
    49
    50